Experimental cancer therapeutics delivered to tumors via nanoparticles could provide a safer and more effective therapy than conventional chemotherapy.
The Scientist
Most Recent
A new class of immune cell could protect against type 1 diabetes by suppressing other immune cells.
Patients with major depressive disorder appear to have malfunctioning circadian rhythms, which could lead researchers to new avenues for treatment.
Telomeres and disease; Wolbachia-infected mosquitoes may fight malaria; bat tongue mops nectar; newly sequenced genomes
Artificially induced bacterial infections in mosquitoes could reduce the spread of malaria-causing parasites.
A small protein produced by fat cells appears to regulate blood sugar levels, potentially revealing a new way to treat diabetes.
Hybrid viruses derived from an H5N1 bird flu strain can infect guinea pigs through the air.
Scientists create biocompatible, self-luminescing nanoparticles for in vivo imaging.
Research Associate, Perelman School of Medicine, University of Pennsylvania. Age: 27
Sorting out T-cell functional and phenotypic heterogeneity depends on studying single cells.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
